Oxygen-exacerbated bleomycin pulmonary toxicity.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1704473.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bleomycin is an antineoplastic agent with potential for producing pulmonary toxicity, attributed in part to its free radical-promoting ability. Clinical and research experiences have suggested that the risk of bleomycin-induced pulmonary injury is increased with the administration of oxygen. We report a case in which the intraoperative administration of oxygen in the setting of previous bleomycin therapy contributed to postoperative ventilatory failure. Our patient recovered with corticosteroid therapy. Physician awareness of a potential interaction between oxygen and bleomycin may help reduce the morbidity and mortality related to bleomycin therapy.
Medical subject headings
- Acute Disease
- Adult
- Bleomycin
- Bleomycin/adverse effects
- Drug Synergism
- Humans
- Intraoperative Care
- Lung Neoplasms
- Lung Neoplasms/drug therapy
- Male
- Neoplasm Recurrence, Local
- Neoplasm Recurrence, Local/surgery
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Germ Cell and Embryonal/drug therapy
- Oxygen Inhalation Therapy
- Oxygen Inhalation Therapy/adverse effects
- Reoperation
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome/chemically induced